Диссертация (1151523), страница 16
Текст из файла (страница 16)
– Vol. 35. – P. 1350-1352.91.Birch, N.P. Distribution of carboxypeptidase H messenger RNA in rat brainusing in situ hybridization histochemistry: implications for neuropeptidebiosynthesis /N.P.Birch, C.Rodriguez, J.E.Dixon, E.Mezey // Brain Research.Molecular Brain Research. – 1990. – Vol. 7, N 1. – P.
53-59.92.Birks, J. Ginkgo biloba for cognitive impairment and de mentia /J. Birks,Evans J.Grimley // Cochrane Database of Systematic Reviews. – 2009. – Issue1. Art. No.: CD003120. DOI: 10.1002/14651858.CD003120.pub3.93.Bokisch, V.A. Anaphylatoxin inactivator of human plasma: it’s isolation andcharacterization as a carboxypeptidase / V.A.Bokisch, H.J.Müller-Eberhard //Journal of Clinical Investigation. – 1970. – N 49. – P. 2427 – 2436.94.Bondy, C.A. Regulation of carboxypeptidase H gene expression inmagnocellular neurons: response to osmotic stimulation /C.A.Bondy,M.H.Whitnall, L.S.Brady // Molecular Endocrinology. – 1989. – Vol.
3, N 12.– P. 2086 – 2092.95.Bukanova Ju., Solnzeva E., Skrebitsky V.G. Selective suppression of the slowinactivating potassium currents by nootropics in molluscan neurons/Ju.Bukanova, E.Solnzeva, V.G.Skrebitsky // International Journal ofNeuropsychopharmacology. – 2002. – Vol. 5. – P. 229 – 237.10496.Bunning, P. Sulfate potentiation of the chloride activation of angiotensinconverting enzyme /P.Bunning, F.Riordan // Biochemistry. – 1987.
– Vol. 26.– P. 3374 –3377.97.Cao, H. DNA polymorphism and mutations in CPN1, including the genomicbasis of carboxypeptidase N deficiency /H.Cao, R.A. Hegele // Journal ofHuman Genetics. – 2003. – N 48. – P. 20 – 22.98.Chen, Q. Vasopressin-induced neurotrophism in cultured neurons of thecerebral cortex: dependency of calcium signaling and protein kinase activity/Q.Chen, R.Patel, A.Sales // Neuroscience. – 2000.
– Vol. 101, N 1. – P. 19 –26.99.Chouinard, G. Piracetam in elderly psychiatric patients with mild diffusecerebral impairment /G.Chouinard, L.Annable, A.Ross-Chouinard, M.Olivier,F.Fontaine // Psychopharmacology. – 1983. – Vol. 2, N 81. – P. 100-106.100. Cohen, S.A. Effects of piracetam on N-methyl-D-aspartate receptorproperties in the aged mouse brain /S.A.Cohen, W.E.Müller // Pharmacology.
–1993. – Vol. 47, N 4. – P. 217 – 222.101. Cooke, S.F. Plasticity in the human central nervous system /S.F.Cooke,T.V.Bliss // Brain. – 2006. – Vol. 129. – P. 1659 – 1673.102. Dakes, M.J. The ontogeny of enzymes involved in posttranslationalprocessing and metabolism of neuropeptides /M.J.Dakes, T.P.Davis //Developmental Brain Research. – 1994. – Vol. 80, N 1-2.
– P. 127 – 136.103. Das, B. Regulation of carboxypeptidase E by membrane depolarization inPC12 pheochromocythoma cells: comparison with the mRNA's encordingother peptide and catecholamine's biosynthetic enzymes /B.Das, E.L.Sablan,E.J.Kilbourne, L.D.Fricker // Neurochemistry. – 1992. – Vol.
59, N 6. – P.2263 – 2270.104. Davidson,H.W.The insulin-secretory-granule carboxypeptidase H:Purification and demonstration of involvement in proinsulin processing/H.W.Davidson, J.C.Hutton // Biochemistry. – 1987. – Vol. 245, N 2. – P. 575– 582.105105.
Davis, D.A. Identification of carboxypeptidase N as an enzyme responsiblefor C-terminal cleavage of stromal cell- derived factor-1alpha in the circulation/D.A.Davis, K.E.Singer, M.De La Luz Sierra, M.Narazaki, F.Yang,H.M.Fales, R.Yarchoan, G.Tosato // Blood. – 2005. – Vol. 105, N 12. – P.4561-4568.106.
De La Luz Sierra, M. Differential processing of stromal-derived factor1alpha and stromal-derived factor-1beta explains functional diversity /M.De LaLuzSierra,F.Yang,M.Narazaki,O.Salvucci,D.Davis,R.Yarchoan,H.H.Zhang, H.Fales, G.Tosato// Blood. – 2004. – Vol. 103, N 7. – P. 2452 –2459.107. De Reuck, J. The clinical safety of high-dose piracetam – it’s use in thetreatment of acute stroke /J.De Reuck, B.Van Vleymen // Pharmacopsychiatry.– 1999. – Vol. 32, Suppl 1. – P. 33-37.108.
De Wied, D. Neurochemical and psychopharmacological approaches tocognitive entracers /D.De Wied // Kyoto. – 1995. – P. 48.109. Demmer, W. Processing and degradation of Met-enkephalin by peptidaseassociated with rat brain cortical synaptosomes /W.Demmer, R.Brand //Proteasey potential role in health and disease. Prot. International SymposiumWirsburg.
17-20 Oct. – 1982. P. 165–177.110. Dochetry, K. Carboxypeptidase activity in the insulin secretory granule/K.Dochetry, J.C. Hutton // FEBS Letters. – 1983. – Vol. 162, N 1. – P. 137 –141.111. Ehlers, M.R. Angiotensin-converting enzyme: new concepts concerning itsbiological role /M.R.Ehlers, I.E.Riordan // Biochemistry.
– 1989. – Vol. 28, N.3. – P. 5311 – 5318.112. Erdös, E.G. Kininases. Handbook of Experimental Pharmacology /E.G.Erdös // Heidelberg, Springer-Verlag, 1979 (suppl. to Vol. XXV). – P. 427–487113. Erdös, E.G. The angiotensin-I-converting enzyme /E.G.Erdös, R.A.Skidgel// Laboratory investigation. – 1987. – Vol. 56. – P. 345 – 348.106114. Erdös, E.G. An enzyme in human blood plasma that inactivates bradykininand kallidins /E.G.Erdös, E.M. Sloane // Biochemical Pharmacology. – 1962.
–N 11. – P. 582 – 592.115. Fedi, M.Long-term efficacy and safety of piracetam in the treatment ofprogressive myoclonus epilepsy /M.Fedi, D.Reutens, F.Dubeau, E.Andermann,D.D'agostino, F.Andermann // Archives of neurology. – 2001. – Vol. 58, N 5. –P. 781–786.116. Fiedorek, F.T. Carboxypeptidase H processing and secretion in rat clonalbeta cell lines /F.T. Jr.Fiedorek, D.Parkinson // Endocrinology. – 1992.
– Vol.131, N 3. – P. 1054 –1062.117. Firstova, Yu.Yu. The effects of scopolamine and the nootropic drugphenotropil on rat brain neurotransmitter receptors during testing of theconditionedpassiveavoidancetask/Yu.Yu.Firstova,D.A.Abaimov,I.G.Kapitsa, T.A.Voronina, Kovalev G.I.// Neurochemical Journal. – 2011. –Vol. 28 N 2. – P. 130-141.118.
Fricker, L.D. Activation and membrane binding of carboxypeptidase E/L.D.Fricker // Journal of cellular biochemistry. – 1988. – № 38. – P. 279 –289.119. Fricker, L.D. Isolation and sequence analysis of cDNA for ratcarboxypeptidase E [EC 3.4.17.10], a neuropeptide processing enzyme/L.D.Fricker, J.P.Adelman, J.Douglass// Molecular endocrinology. – 1989. –Vol. 3, N 4. – P. 666 – 673.120. Fricker, L.D. Identification of the pH dependent membrane anchor ofcarboxypeptidase E (EC 3.4.17.10) /L.D.Fricker, B.Das, R.H.Angeletti // TheJournal of biological chemistry. – 1990. – Vol. 265, N 5.
– P. 2476 – 2282.121. Fricker, L.D. Regulation of carboxypeptidase E (enkephalin convertase)/L.D.Fricker, B.Das, R.S.Klein, D.Greene, Y.K.Jung // NIDA researchmonograph. – 1991. – № 111. – P. 171 – 187.122. Fricker, L.D. Posttranslational processing of carboxypeptidase E, aneuropeptide processing enzyme, in AtT 20 cells and bovine pituitary secretory107granules /L.D.Fricker, L.Devi // Journal of neurochemistry. – 1993.
– Vol. 61,N 4. – P. 1404 – 1415.123. Fricker, L.D. Comparison of a carboxypeptidase E-like enzyme in human,bovine, mouse, Xenopus, shark and Aplysia neural tissue /L.D.Fricker,E.Herbert // Brain research. – 1988. – Vol. 453, N 1-2. – P. 281 – 286.124. Fricker, L.D. Enkephalin convertase: potent, selective and irreversibleinhibitors /L.D.Fricker, T.H.Plummer, S.H.Snyder // Biochemical andbiophysical research communications. – 1983. – Vol. 11, N 3. – P.
994 – 1000.125. Fricker, L.D. Enkephalin convertase: purification and charasterization of aspecific enkephalin-synthesizing carboxypeptidase localized to adrenallchromaffin granules /L.D.Fricker, S.H.Snyder // Proceedings of the NationalAcademy of Sciences of the United States of America. – 1982. – Vol. 79. – P.3886 – 3890.126. Fricker, L.D. Purification and characterization of enkephalin convertase, anenkephaline-synthesizing carboxypeptidase /L.D.Fricker, S.H. Snyder // TheJournal of biological chemistry. – 1983. – Vol. 258, N 18.
– P. 10950 – 10955.127. Fricker, L.D. Enkephalin convertase: a specific enkephalin synthesingcarboxypeptidase in adrenal chromaffin granules, brain and pituitary gland/L.D.Fricker, S.Supattapone, S.H.Snyder // Life sciences. – 1982. – Vol. 31.
–P. 1841 – 1844.128. Ganten, D. Angiotensin-forming enzymein brain tissue /D.Ganten,J.L.Minnich, P.Grander, et al.// Ibid. – 1971. – Vol. 173. – P. 64 – 65.129. Giurgea Corneliu, E. The nootropic concept and its prospective implications/E.Giurgea Corneliu // Drug Development Research. – 1982.
– Vol. 2, N 5. – P.441 – 446.130. Gouliaev, A.H. Piracetam and other structurally related nootropics/A.H.Gouliaev, A.Senning // Brain research. Brain research reviews. – 1994. –Vol. 19, N 2. – P. 180 – 222.108131. Grau, M. Effect of Piracetam on electrocorticogram and local cerebralglucose utilization in the rat /M.Grau, J.L.Montero, J.Balasch // Generalpharmacology. – 1987. – Vol. 18, N 2. – P. 205 – 211.132. Grigoriants, O. Dopamine antagonist haloperidol increases carboxypeptidaseE mRNA in rat neurointermediate pituitary but not in various other rat tissues/O.Grigoriants, L.Devi, L.D.Fricker // Brain research.
Molecular brainresearch. – 1993. – Vol. 19. – P. 161 – 164.133. Grimwood, B.G. Carboxypeptidase H. A regulatory peptide-processingenzyme produced by human hepatoma Hep G2 cells /B.G.Grimwood, T.H.Jr.Plummer, A.L.Tarentino // The Journal of biological chemistry. – 1989. –Vol. 264, N 26. – P. 15662 – 15667.134. Gudasheva, T.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
